Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying their treatment.

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky ...

Over at New Mexico Cancer Center, clinical trials play a vital role in making sure their treatments are safe and effective.

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases.

Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of ...

The new 300-bed tower, built in partnership with Beth Israel Deaconess Medical Center, would reshape the delivery of cancer ...

The University of Rochester’s Wilmot Cancer Institute has received the prestigious federal Cancer Center designation from the ...

ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announces its ...

Nanaimo Regional General Hospital (Nanaimo, British Columbia, Canada) selected Stantec as architect for its new BC Cancer Center in Nanaimo.